All Online

385 - 396 of 689 results

Refine

Active filters

1 CME CREDIT

Watch expert faculty discuss assess and treat migraine through the case of a young man with recurrent headaches. Treatment will focus on traditional and new preventive therapies for chronic migraine as well as patient self-management strategies to optimize management. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 8/13/2020, and they are subject to change as new information is published.


0.25 CME CREDIT

Leg Cramps in Seniors: Could Alcohol Be the Cause? - Frankly Speaking EP 105

Guest: Alan Ehrlich MD Music Credit: Richard Onorato

0.25 CME

This episode will discuss a Case Control study of seniors to determine if there is a relationship between regular alcohol consumption and nocturnal leg cramps.


Strategies for Effective Pain Management

6.75 CME/MOC
7.10 AANP | 3.14 Pharmacology


0.25 CME CREDIT

Is Aspirin Effective for Primary Prevention? - Frankly Speaking EP 104

Guest: Alan Ehrlich MD Music Credit: Richard Onorato

0.25 CME

For patients with established cardiovascular disease,aspirin is clearly beneficial as part of secondary prevention. However, when used as primary prevention in patients without documented cardiovascular disease, its benefit is much less certain. This podcast will explore 3 recent trials that evaluated aspirin in different populations and found nobenefit for its use as primary prevention.


0.3 CME CREDIT

The Advisory Committee on Immunization Practices (ACIP) makes shared clinical decision-making recommendations when individuals may benefit from vaccination, but broad vaccination of all people in that group is unlikely to have population-level impact. Such a recommendation is applicable to pneumococcal vaccines whereby pneumococcal conjugate vaccine (PCV13) is recommended for all adults 65 and older, while the administration of pneumococcal conjugate vaccine (PCV13) is based on shared decision-making. In this podcast, we will discuss the ACIP recommendations and the use of shared decision-making as it applies to pneumococcal vaccines. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/18/2020 and they are subject to change as new information is published.


0.3 CME CREDIT

Adults between the ages of 18 through 64 with immunocompromising conditions due to either anatomic defects or impaired immune response are at the highest risk for invasive pneumococcal disease. They need two different pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13) at the time the risk factor is recognized and pneumococcal polysaccharide vaccine (PPSV23) at least 8 weeks later. This podcast will discuss how to identify these patients at high risk for pneumococcal disease and implement guidelines for administration of pneumococcal vaccination in this population. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/18/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

Treating chronic pain in older individuals and balancing analgesia and adverse effects in this population, which is often afflicted with multiple comorbidities, is challenging. This program reviews the assessment and nonpharmacologic treatment of chronic pain in patients aged 65 years and older. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


0.25 CME CREDIT

Favorite Podcast of the Last 200! - Frankly Speaking EP 200

Guests: Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien PhD, ANP-BC; Robert Baldor, MD, FAAFP; Alan Ehrlich, MD, FAAFP Music Credit: Richard Onorato

0.25 CME

Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful. .


This short curriculum cuts to the heart of primary and secondary cardiovascular disease prevention in people with type 2 diabetes. The following two activities will help you individualize treatment and optimize adherence through shared decision-making tactics that account for CV risk factors, comorbidities, and patient preferences. This curriculum includes: • 1 educational video webcast • 1 simulated digital “tele-visit” with a standardized patient Pri-Med has partnered with RealCME to offer the Pri-Med community the innovative opportunity to schedule time for a simulated digital “tele-visit” with a standardized patient (SP), who is trained to simulate the symptoms and characteristics of patients you see in your practice. This interactive session is designed to complement the “Heart of the Matter” video webcast by enabling you to practice shared-decision making. You can benefit from scheduling this activity after viewing the educational webcast, but you are also welcome to sign up for this simulated digital tele-visit activity without viewing the webcast. The “patient” is a 52-year-old who is following up with you for their type 2 diabetes, with a history of obesity, hypertension, hypercholesterolemia, and coronary artery disease. The patient is on maximum dose of metformin, with an A1c today of 8.6%. A highly experienced observer will review your session and send you feedback via a customized scorecard. There is no cost for this activity, but there are limited sessions available. To schedule your free virtual visit, you will need this access code: PriMed2020 Link to activity: https://m.pri-med.com/T1ZMR080r000iMb30E5hYA0 Access code: PriMed2020


0.35 CME CREDIT

Pain Points: Nonopioid Pharmacologic Options in Older Adults

0.25 CME/MOC
0.35 AANP | 0.23 Pharmacology

Nonopioid therapy is an important tool for the treatment of chronic pain. But agents differ as to efficacy and safety in older patients. This program reviews the different classes of nonopioid medications, their efficacy in different types of pain, and their use in older patients. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).